| Symbol | ALC |
|---|---|
| Name | ALCON INC |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Ophthalmic Goods |
| Address | 6201 SOUTH FREEWAY, FORT WORTH, TX 76134 |
| Telephone | 817 293 0450 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001167379 |
| Description | Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan. Additional info from NASDAQ: |
Alcon - Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
Read moreAlcon lance UNITYMD CS au Congrès de la SCO 2026, qui marque une avancée majeure dans la prochaine génération d’innovations chirurgicales au Canada
Read moreAlcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada
Read moreNew Form SD - ALCON INC <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001167379-26-000025 <b>Size:</b> 53 KB
Read moreAlgoma Central Corporation Reports Financial Results for the 2026 First Quarter
Read moreAlcon - New Product Launches Drive Alcons First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
Read moreNew Product Launches Drive Alcons First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
Read more